AstraZeneca/Oxford Vaccine

The AstraZeneca/Oxford vaccine, officially known as Vaxzevria, is a COVID-19 vaccine developed by AstraZeneca in collaboration with the University of Oxford. It's a viral vector vaccine, meaning it uses a harmless virus to deliver a piece of the coronavirus's genetic material to stimulate an immune response. This helps the body recognize and fight the actual virus if exposed in the future. The vaccine is administered in two doses and has been shown to reduce the risk of severe illness and hospitalizations from COVID-19, contributing to global efforts to control the pandemic.